Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Oric Pharmaceuticals, Inc. (ORIC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/11/2023 |
4
| Chacko Jacob (President and CEO) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Sold 10,508 shares
@ $8.0141, valued at
$84.2k
Sold 5,156 shares
@ $8.0076, valued at
$41.3k
|
|
| 07/07/2023 |
4
| Chacko Jacob (President and CEO) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Sold 4,336 shares
@ $8.0052, valued at
$34.7k
|
|
| 06/28/2023 |
4
| Chacko Jacob (President and CEO) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Sold 20,000 shares
@ $8.0281, valued at
$160.6k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2022 |
4
| Piscitelli Dominic (CFO) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Bought 60,000 shares
@ $5.3604, valued at
$321.6k
|
|
| 03/25/2022 |
4
| Chacko Jacob (President and CEO) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Bought 257,127 shares
@ $4.9815, valued at
$1.3M
Bought 42,873 shares
@ $5.0302, valued at
$215.7k
Bought 50,000 shares
@ $4.5434, valued at
$227.2k
|
|
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2021 |
4
| COLUMN GROUP II, LP (10% Owner) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Disposed of 1,200,000 shares
@ $0
Acquired 287,702 shares
@ $0
Disposed of 287,702 shares
@ $0
Acquired 86,716 shares
@ $0
Acquired 86,716 shares
@ $0
Acquired 74 shares
@ $0
Exercised 16,625 options to buy
@ $16, valued at
$266k
|
|
| 11/10/2021 |
4
| You Angie (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Granted 33,250 options to buy
@ $17.42, valued at
$579.2k
|
|
| 09/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|